All News Anagenics Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:03:34 26/06/2024 am IST			5-day change	1st Jan Change
0.007 ^AUD	-12.50%		+16.67%	-63.16%

24/05	Anagenics Signs Midkine Antibody Licencing Deal with Roquefort Therapeutics	MT
08/03	Anagenics Appoints CEO	MT

Anagenics Signs Midkine Antibody Licencing Deal with Roquefort Therapeutics	24/05	MT
Anagenics Appoints CEO	08/03	MT
Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02	CI
Anagenics Completes Placement to Raise AU$1.3 Million	07/02	MT
Anagenics Grows Fiscal H1 Revenue	31/01	MT
Anagenics Acquires Face Medi Group	02/23/02	MT
Anagenics Limited Announces Board Executive Changes	02/23/02	CI
Anagenics Limited completed the acquisition of Face MediGroup.	02/23/02	CI
Anagenics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/23/30	CI
Anagenics Limited agreed to acquire Face MediGroup for AUD 1.3 million.	22/23/22	CI
Anagenics Appoints CEO/Managing Director	29/23/29	MT
Anagenics Limited Appoints Scott Greasley as Managing Director, Effective from 1 April 2023	29/23/29	CI
Anagenics Limited Announces CEO Changes	29/23/29	CI
Anagenics Raises Funds from Institutional Entitlement Offer	16/23/16	MT
Rights Issue: 1 new share @ 0.022 AUD for 1.3748 existing shares	16/23/16	FA
Anagenics Raising AU$3.2 Million Via Entitlement Offer	14/23/14	MT
Anagenics Limited Appoints Karen Matthews as Non-Executive Director	14/23/14	CI
Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	13/23/13	CI
Anagenics Limited acquired Uspa Global Pty. Ltd. from BWX Limited.	09/22/09	CI
Anagenics : FY2022 Annual Report	05/22/05	PU

No results for this search